Medicare Enrolled
Dr. Miguel Mercado, MD
Urology Physician · Tomball, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mercado from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mercado?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mercado
Dr. Miguel Mercado is an urology physician in Tomball, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Mercado performed 4,687 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mercado received a total of $20,893 from 41 pharmaceutical and/or device companies across 307 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mercado is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 25% volume in TX
$20,893 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,687
Medicare services
Top 25% in TX for urology physician
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
871 | $34 | $166 |
| Leuprolide injectable, camcevi, 1 mg | 756 | $65 | $247 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
699 | $2 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
497 | $88 | $368 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
293 | $8 | $97 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $61 | $250 |
| Nucleic acid test for organism quantification A laboratory test that uses nucleic acid detection to measure the amount of a specific organism present in a sample. |
199 | $42 | $222 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
145 | $111 | $565 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
97 | $182 | $684 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
68 | $633 | $3,366 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
67 | $34 | $123 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
67 | $34 | $182 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
67 | $34 | $153 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
67 | $34 | $153 |
| Strep A nucleic acid test, quantification A laboratory test that uses nucleic acid detection to identify and measure the amount of Group A Streptococcus bacteria. |
67 | $41 | $146 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
67 | $34 | $123 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $59 | $247 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
39 | $100 | $470 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
32 | $16 | $68 |
| Chlamydia trachomatis nucleic acid test, quantitative A laboratory test that uses nucleic acid amplification to detect Chlamydia trachomatis and measure the amount of the organism present. |
31 | $52 | $187 |
| Gonorrhea nucleic acid test, quantification A laboratory test that uses nucleic acid amplification to detect and measure the amount of gonorrhea bacteria in a sample. |
31 | $42 | $150 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
31 | $34 | $168 |
| Gardnerella vaginalis detection and quantification test A laboratory test that detects the presence of Gardnerella vaginalis bacteria and measures the amount present in a sample. |
30 | $41 | $146 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
22 | $51 | $296 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
19 | $25 | $145 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
18 | $19 | $61 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
15 | $183 | $775 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
15 | $45 | $633 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
14 | $306 | $1,205 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
14 | $6 | $277 |
| Assessment of muscle signal of pelvic nerves This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control. |
14 | $107 | $747 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
14 | $152 | $522 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
14 | $59 | $322 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
13 | $911 | $4,403 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$20,893
Total received (2018-2024)
Avg $2,985/year across 7 years
Top 11% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
307
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,611
2023
$1,634
2022
$1,936
2021
$816
2020
$4,252
2019
$4,347
2018
$6,297
Payments by company (2024)
Axonics, Inc.
$433
BIOTISSUE HOLDINGS INC.
$295
Sumitomo Pharma America, Inc.
$273
Boston Scientific Corporation
$89
PROCEPT BioRobotics Corporation
$83
ACCORD HEALTHCARE, INC.
$70
Endo USA, Inc.
$68
Ferring Pharmaceuticals Inc.
$60
Astellas Pharma US Inc
$43
Endo Pharmaceuticals Inc.
$40
Myriad Genetic Laboratories, Inc.
$38
ARGON MEDICAL DEVICES, INC.
$32
180 Medical, Inc.
$23
COLOPLAST CORP
$23
PFIZER INC.
$21
Antares Pharma, Inc.
$19
Top 3 companies account for 62.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$7,557
Coloplast Corp
$3,546
BOSTON SCIENTIFIC CORPORATION
$3,292
Axonics, Inc.
$1,451
PROCEPT BioRobotics Corporation
$553
Teleflex LLC
$551
Astellas Pharma US Inc
$520
NeoTract Inc.
$327
Sumitomo Pharma America, Inc.
$317
BIOTISSUE HOLDINGS INC.
$295
Olympus America Inc.
$293
ACCORD HEALTHCARE, INC.
$221
Endo Pharmaceuticals Inc.
$204
COLOPLAST CORP
$189
Dornier MedTech America, Inc
$138
Janssen Biotech, Inc.
$136
PFIZER INC.
$135
Palette Life Sciences, Inc.
$125
Laborie Medical Technologies Corp.
$124
Allergan Inc.
$83
UROVANT SCIENCES INC
$82
Myriad Genetic Laboratories, Inc.
$80
Bayer HealthCare Pharmaceuticals Inc.
$75
Endo USA, Inc.
$68
ABBVIE INC.
$61
Ferring Pharmaceuticals Inc.
$60
180 Medical, Inc.
$47
NxThera, Inc.
$45
C. R. Bard, Inc. & Subsidiaries
$39
Antares Pharma, Inc.
$37
ARGON MEDICAL DEVICES, INC.
$32
ConvaTec Inc.
$30
PALETTE LIFE SCIENCES, INC.
$28
Duchesnay USA Incorporated
$25
Sun Pharmaceutical Industries Inc.
$24
MEDIVATION FIELD SOLUTIONS LLC
$23
EDAP TECHNOMED INC
$23
Allergan, Inc.
$16
Amgen Inc.
$14
Axonics Modulation Technologies, Inc.
$13
UroGen Pharma, Inc.
$12
Top 3 companies account for 68.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS · AQUABEAM SYSTEM · AVEED · Altis · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · Clot Management · Erleada · FLEXIVA · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GREENLIGHT · JELMYTO · LITHOVUE · Lithotripters & Accessories · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · Osphena · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · Porges Coloplast · Prolia · RESTORELLE · Rezum · SWISS LITHOCLAST TRILOGY · SpaceOAR VUE System - 10mL · SpeediCath · TACTRA · TITAN · TLANDO · TOROSA · TOVIAZ · Titan · UROLIFT · UroLift · UroLift 2 System · UroLift System · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
62
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mercado is a clinical cardiology specialist, with above-average Medicare volume (top 25% in TX), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mercado experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Mercado performed 871 infectious disease dna/rna test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mercado receive payments from pharmaceutical companies?
Yes. Dr. Mercado received a total of $20,893 from 41 companies across 307 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mercado's costs compare to other urology physicians in Tomball?
Dr. Mercado's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mercado) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Tomball
Browse urology physicians in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology